New Tests

Test Number Test Name

Effective Date 1/30/2017

2014168 Alagille Syndrome (JAG1) Sequencing and Microarray

Effective Date 1/23/2017

2014183 Ibuprofen Quantitative, Serum or Plasma
2014180 Fluoxetine and Metabolite Quantitative, Serum or Plasma

Effective Date 1/17/2017

2014011 Allergen, Food, Alpha-Gal (Galactose-Alpha-1,3-Galactose) Panel
2014093 Filaria Antibody IgG4 by ELISA, Serum

Effective Date 1/3/2017

2014073 HLA-DP Genotyping
2014079 HLA-DQ Genotyping

Effective Date 12/27/2016

2013956 CV2.1 Screen by IFA with Reflex to Titer
2013944 Autoimmune Neurologic Disease Reflexive Panel
2013955 Paraneoplastic Reflexive Panel

Effective Date 12/20/2016

0013410 Thermal Amplitude Test

Effective Date 12/05/2016

2013566 Insulin, 180 Minutes
2014027 Calcium, RBC
2014041 Potassium, RBC
2014035 Familial Transthyretin Amyloidosis (TTR) Sequencing

Effective Date 11/21/2016

2014069 Zika Virus by PCR, Urine
2014065 Zika Virus by PCR, Blood
2013961 Myositis Extended Panel
2013992 Polymyositis and Dermatomyositis Panel
2013991 Dermatomyositis Panel
2013993 Interstitial Lung Disease Panel
2013990 Polymyositis Panel

Effective Date 11/16/2016

2014000 Expanded Carrier Screening Next Generation Sequencing
2014059 Prostate-Specific Kallikrein, 4Kscore

Effective Date 11/15/2016

2014025 Trypsin

Effective Date 11/14/2016

2014056 IgA Deficiency (IgAD) Panel
2013725 ABCC8-Related Hyperinsulinism, 3 Variants
2013909 Joubert Syndrome Type 2 (TMEM216), 1 Variant
2013745 NEB-Related Nemaline Myopathy, 1 Variant
2013740 Glycogen Storage Disease, Type 1A (G6PC), 9 Variants
2013735 Lipoamide Dehydrogenase Deficiency (DLD), 2 Variants
2013730 Maple Syrup Urine Disease, Type 1B (BCKDHB), 3 Variants
2013750 Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
2013921 BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
2013890 Toxoplasma gondii Antibody, IgA by ELISA, Serum
2013897 Herpes Simplex Virus (HSV) Typing
2013805 Natural Killer Cell and Natural Killer T-Cell Panel
2013802 LANGERIN by Immunohistochemistry
2013768 Chlamydia trachomatis L serovars (LGV) by PCR
2013767 Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA) with reflex to Chlamydia trachomatis L serovars (LGV) by PCR

Effective Date 11/7/2016

2014043 Amphetamines (D/L Differentiation), Urine

Effective Date 10/18/2016

2013929 Growth Hormone, 150 Minutes
2013927 Growth Hormone, 180 Minutes

Effective Date 10/10/2016

2013942 ZikaVirus IgM Antibody Capture (MAC), by ELISA